New Jersey will receive about $2.7 million as part of a $125-million, multi-state settlement with the pharmaceutical company Cephalon over allegations the company illegally monopolized the market for one of its drugs.
Local News from NorthJersey.com, The Record
Thu, 08/04/2016 - 12:15pm
New Jersey will receive about $2.7 million as part of a $125-million, multi-state settlement with the pharmaceutical company Cephalon over allegations the company illegally monopolized the market for one of its drugs.